Market Research Reports

Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia Pacific and Rest of the World) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

86pages
Published Date: 2014-11-18
 

Description



A rise in the global geriatric population, increasing number of patients suffering from Parkinson’s disease (PD) and growing awareness about neurological movement disorders among patients have triggered the growth of the deep brain stimulation devices market. Globally, neurological disorders are one of the major causes of mortality and account for approximately 12% of deaths per annum. Of these, cerebrovascular diseases account for 85% deaths. Parkinson’s disease is the most common neurological disorder after Alzheimer’s disease. Symptoms associated with this disease include tremors, slowness of movement, muscle stiffness and trouble with balance. Drug therapy is the most effective treatment option available to control PD in the initial stages; however, a large number of medicines are required to control the disease during its advanced stages. In the later stages of PD, surgical treatment using deep brain stimulation (DBS) devices is used to control symptoms of the disease. DBS devices are an effective, clinically proven and legally approved advanced treatment option for mild to severe PD. The market for DBS devices is expected to grow at a significant rate during the forecast period from 2014 to 2020. However, the high cost of the surgical procedure could hamper the growth of the market. The growing burden of PD on health care systems, along with the uncertainty of economic conditions in some developed economies such as the U.S. and Europe has forced original equipment manufacturers (OEMs) to develop cost-effective devices for PD treatment.

This market research report on DBS devices for the treatment of Parkinson’s disease provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of the market. The report discusses the market for deep brain stimulation devices for Parkinson’s disease based on prevalence of the disease and the use of these devices to treat PD in four geographical regions: North America, Europe, Asia Pacific and Rest of the World. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information on various segments and sub-segments that are included in the scope of the study. It also provides overall information and data analysis of the global market for deep brain stimulation devices for Parkinson’s disease with respect to market segments based on geography (i.e., region-wise and country-wise analyses).

The global market for DBS devices for Parkinson’s disease has been segmented with respect to geography. Market size estimates and forecasts for the period from 2012 to 2020 have been provided for each geographical region in terms of revenue (USD million), considering 2012 and 2013 as historical and base years, respectively. The CAGR (%) of each market segment for the forecast period from 2014 to 2020 has also been provided along with market size estimations. The market overview section provides a detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global market for deep brain stimulation devices for the treatment of Parkinson’s disease. The section also covers opportunities, Porter’s five forces analysis as well as market attractiveness analysis and market share analysis of major players in the global DBS devices market.

A list of recommendations has been provided for new entrants and existing market players to help them establish a strong presence in the market and increase their share. The report also profiles the major players in the market for deep brain stimulation devices for Parkinson’s disease based on various attributes. The profiles include company overview, financial overview, business strategies, product portfolio and recent developments. Prominent players profiled in the report include Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation and Aleva Neurotherapeutics SA.

Global deep brain stimulation devices market for Parkinson’s disease is segmented as follows:

Deep Brain Stimulation Devices Market, By Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Australia
    • New Zealand
    • Japan
    • India
    • China
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Brazil
    • Mexico
    • Rest of RoW

Table of Contents


Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
2.2 Comparative Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography, 2013 & 2020 (Value %)

Chapter 3 Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Overview
3.1 Introduction
3.2 Market Drivers
      3.2.1 Rapidly Aging Population Leading to Rising Risk and High Prevalence of Neurological Disorders such as Parkinson’s disease, Alzheimer’s disease, Dementia, etc.
      3.2.2 Growing Demand for Deep Brain Stimulation Devices due to Rising Popularity of Minimally Invasive Procedures
      3.2.3 Favorable Reimbursement Scenario would add to the Increased Acceptance of DBS Devices Globally
      3.2.4 Availability of Technologically Advanced Deep Brain Stimulation Devices would Further Boost Market Growth
3.3 Market Restraints
      3.3.1 Risks Associated with Deep Brain Stimulation Procedures
      3.3.2 Implementation of Certain Government Policies such as the Affordable Care Act in the U.S. Negatively Affects the DBS Devices Market
3.4 Market Opportunities
      3.4.1 Address the High Unmet Needs of the Patient population in the Emerging Economies of the World
3.5 Porter’s Five Forces Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of Substitutes
      3.5.4 Threat of New Entrants
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography
3.7 Competitive Landscape
      3.7.1 Market Share Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s disease, 2013 (Value %)

Chapter 4 Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography
4.1 Overview
      4.1.1 Global Prevalence of Parkinson’s Disease, by Geography, 2012 – 2020 (Number of Patients)
      4.1.2 Global Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Geography, 2012 – 2020
      4.1.3 Global Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Geography, 2012 – 2020 (USD Million)
4.2 North America
      4.2.1 North America Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients)
      4.2.2 North America Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020
      4.2.3 North America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Country, 2012 – 2020 (USD Million)
      4.2.4 United States
              4.2.4.1 United States Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue, 2012 – 2020 (USD Million)
      4.2.5 Canada
               4.2.5.1 Canada Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue, 2012 – 2020 (USD Million)
4.3 Europe
      4.3.1 Europe Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients)
      4.3.2 Europe Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020
      4.3.3 Europe Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Country, 2012 – 2020 (USD Million)
      4.3.4 Germany
              4.3.4.1 Germany Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue, 2012 – 2020 (USD Million)
      4.3.5 Italy
              4.3.5.1 Italy Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
      4.3.6 Spain
              4.3.6.1 Spain Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
      4.3.7 United Kingdom
              4.3.7.1 United Kingdom Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
      4.3.8 France
              4.3.8.1 France Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
      4.3.9 Rest of Europe (RoE)
              4.3.9.1 RoE Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
4.4 Asia Pacific      
      4.4.1 Asia Pacific Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients)
      4.4.2 Asia Pacific Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020
      4.4.3 Asia Pacific Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by   Country, 2012 – 2020 (USD Million)
      4.4.4 Australia
              4.4.4.1 Australia Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
      4.4.5 China
              4.4.5.1 China Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
      4.4.6 India
              4.4.6.1 India Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
      4.4.7 New Zealand
              4.4.7.1 New Zealand Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
      4.4.8 Japan
              4.4.8.1 Japan Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
      4.4.9 Rest of APAC
              4.4.9.1 Rest of APAC Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
4.5 Rest of the World (RoW)
      4.5.1 RoW Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients)
      4.5.2 RoW Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020
      4.5.3 RoW Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Country, 2012 – 2020 (USD Million)
      4.5.4 Brazil
              4.5.4.1 Brazil Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
      4.5.5 Mexico
              4.5.5.1 Mexico Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
      4.5.6 Rest of RoW
              4.5.6.1 Rest of RoW Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)

Chapter 5 Recommendations
5.1 Improved Product Life and Reduction in the Price of DBS Devices would Create Better Prospects for Players in this Market
5.2 Manufacturing of Deep Brain Stimulation Devices to be Outsourced to Contract Manufacturing Organizations
5.3 Target Emerging Economies of the World for Higher Benefits
5.4 Improve Public Awareness About the Disease, its Consequences as well as Treatment Options and Associated Benefits

Chapter 6 Company Profiles
6.1 Aleva Neurotherapeutics SA
      6.1.1 Company Overview
      6.1.2 Financial Overview
      6.1.3 Product Portfolio
      6.1.4 Business Strategies
      6.1.5 Recent Developments
6.2 Boston Scientific Corporation
      6.2.1 Company Profile
      6.2.2 Financial Overview
      6.2.3 Product Portfolio
      6.2.4 Business Strategies
      6.2.5 Recent Developments
6.3 Medtronic, Inc.
      6.3.1 Company Overview
      6.3.2 Financial Overview
      6.3.3 Product Portfolio
      6.3.4 Business Strategies
6.4 St. Jude Medical, Inc.
      6.4.1 Company Profile
      6.4.2 Financial Overview
      6.4.3 Product Portfolio
      6.4.4 Business Strategies

List of Figures

FIG. 1 Deep Brain Stimulation Devices for Parkinson’s Disease: Market Segmentation
FIG. 2 Global DBS Devices Market for Parkinson’s Disease, by Region, 2013 (USD Million)
FIG. 3 Comparative Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography, 2013 & 2020 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
FIG. 5 Market Attractiveness Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography (2013)
FIG. 6 Market Share by Key Players: Global Deep Brain Stimulation Devices Market for Parkinson’s disease, 2013 (Value %)
FIG. 7 United States Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue, 2012 – 2020 (USD Million)
FIG. 8 Canada Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue, 2012 – 2020 (USD Million)
FIG. 9 Germany Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue, 2012 – 2020 (USD Million)
FIG. 10 Italy Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Spain Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 United Kingdom Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 13 France Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 RoE Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 15 Australia Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 16 China Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 India Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 New Zealand Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 Japan Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 Rest of APAC Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 21 Brazil Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 22 Mexico Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 23 Rest of RoW Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million)
FIG. 24 Boston Scientific Corporation: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 25 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 26 St. Jude Medical, Inc.: Annual Revenue, 2011 – 2013 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
TABLE 2 Relationship Between Age and the Occurrence of Parkinson’s Disease
TABLE 3 Deep Brain Stimulation Device’s U.S. FDA approval for Various Neurological Disorders
TABLE 4 Global Prevalence of Parkinson’s Disease, by Geography, 2012 – 2020 (Number of Patients)
TABLE 5 Global Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Geography, 2012 – 2020
TABLE 6 Global Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Geography, 2012 – 2020 (USD Million)
TABLE 7 North America Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients)
TABLE 8 North America Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020
TABLE 9 North America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Country, 2012 – 2020 (USD Million)
TABLE 10 Europe Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients)
TABLE 11 Europe Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020
TABLE 12 Europe Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Country, 2012 – 2020 (USD Million)
TABLE 13 Asia Pacific Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients)
TABLE 14 Asia Pacific Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020
TABLE 15 Asia Pacific Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Country, 2012 – 2020 (USD Million)
TABLE 16 RoW Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients)
TABLE 17 RoW Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020
TABLE 18 RoW Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Country, 2012 – 2020 (USD Million)

Enquiry Before Buying


Free Market Analysis


Growing pool of geriatric population is observed to be the major cause for the development of various neurological disorders such as Parkinson’s disease (PD), Alzheimer’s disease (AD), dystonia and others. Parkinson’s disease is one of the most common chronic and progressive movement disorders that exhibit the cardinal symptoms of postural instability, bradykinesia, akinesia and tremors due to loss of dopamine producing neurons in substantia nigra of the mid-brain. The mean age of the onset of Parkinson’s disease is 55 to 60 years. According to the Parkinson’s Disease Foundation (PDF), approximately 10 million people are currently living with Parkinson’s disease world over. 

Deep brain stimulation devices market has been categorized on the basis of geography into four major regions, namely North America, Europe, Asia Pacific and Rest of the World (RoW). These geographical regions have been further segmented into major national markets that are located globally, such as, the U.S., Canada, the U.K., Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil among others. Presently, there are multiple treatment options available across geographies to treat patients suffering from various neurological disorders. These include chemotherapy, stem cell therapy, physical therapy and surgical treatment. Most of these therapies are widely used treatment options for Parkinson’s disease. Among drug therapies, the most potent medication is levodopa/carbidopa therapy. Other drugs used to treat PD are dopamine agonists, anti-cholinergic, MAO-B inhibitors and catechol-O-methyl transferase (COMT) inhibitors. However, after long term chemotherapy treatment, the drugs lose their effectiveness. In the advanced stages of Parkinson’s disease, surgical intervention becomes imperative. Presently, surgical interventions that utilize deep brain stimulation (DBS) devices are considered to be highly effective and safer treatment option as compared to other brain surgeries such as thalamotomy, pallidotomy and subthalamotomy. Global market for DBS devices market for treating Parkinson’s disease was valued at USD 1.79 billion in 2013. Among four major regions of the world, North America held the leadership position in terms of revenue with approximately 43.0% share of the global DBS devices market for PD in 2013.

Technological advancement has also aided the growth of this market. Recently, a research team from the Tel Aviv University has been working on an advanced biometric computer chip implant known as Rehabilitation Nano Chip (ReNaChip) that would support healthcare professionals and neurosurgeons in restoring normal brain functions. The innovative ReNaChip would significantly enhance the existing technology known as DBS by delivering electrical stimulation to the appropriate brain area. In addition, companies such as Boston Scientific Corporation has recently introduced its flagship product named “Vercise DBS”. This product is expected to enhance the battery life of the device by 25 years thus competing on pricing with replaceable battery providers for DBS that lasts just for 5 years. Furthermore, an independent unique MICC technology (Multiple Independent Current Control) has been incorporated in Vercise DBS system to control the side-effects of stimulation by controlling the current level at each individual contact on the lead. 

Leading players such as Medtronic, Inc., St. Jude Medical, Inc. and Boston Scientific Corporation are continuously investing in R&D activities to increase the applicability of DBS devices in treating various movement disorders. Currently, the DBS procedure entails implantation of two leads for bilateral stimulation; however, research is currently being carried out to implant multiple lead array systems to stimulate various sites in brain. The three major players of this market i.e. Medtronic, Boston Scientific and St. Jude have created a strong entry barrier for new entrants, hence are dominating this market. However, few new entrants such as Aleva Neurotherapeutics SA, NeuroPace, Inc. and others are expected to launch their new DBS devices in coming years, which are currently under clinical trials for the treatment of Parkinson’s disease.

deep-brain-stimulator-market

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research